Category: LabGenius

LabGenius raises $10M to use AI for protein drug discovery
, ,

LabGenius raises $10M to use AI for protein drug discovery

LabGenius, a London-based startup applying AI and “robotic automation” to protein drug discovery, has raised $10 million in Series A funding. The round is led by Lux Capital and Obvious Ventures, with participation from Felicis Ventures, Inovia Capital, Air Street Capital and existing investors. Also investing is Recursion Pharmaceuticals’ founder and CEO Chris Gibson, as…

Read More